EPHA2 and neoplasm: With respect to EphA2, our results are contradictory to those reported by Brannan et al., who found high EphA2 to be associated with short recurrence time and development of metastasis in NSCLC [6] but also that a high EphA2 expression within tumor conferred short progression-free and overall survival time [5].